Rockwell Medical Inc (RMTI)
1.46
-0.02
(-1.35%)
USD |
NASDAQ |
Apr 30, 13:49
Rockwell Medical 1 Year Total Returns (Daily): -46.38% for April 29, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 29, 2024 | -46.38% |
April 26, 2024 | -35.33% |
April 25, 2024 | -31.05% |
April 24, 2024 | -32.58% |
April 23, 2024 | -28.17% |
April 22, 2024 | -28.87% |
April 19, 2024 | -31.28% |
April 18, 2024 | -31.16% |
April 17, 2024 | -28.50% |
April 16, 2024 | -25.13% |
April 15, 2024 | -23.37% |
April 12, 2024 | -20.79% |
April 11, 2024 | -20.59% |
April 10, 2024 | -20.20% |
April 09, 2024 | -10.99% |
April 08, 2024 | -10.99% |
April 05, 2024 | -9.34% |
April 04, 2024 | -9.63% |
April 03, 2024 | -9.44% |
April 02, 2024 | -8.29% |
April 01, 2024 | -6.08% |
March 28, 2024 | 22.06% |
March 27, 2024 | 16.31% |
March 26, 2024 | 17.86% |
March 25, 2024 | 15.71% |
Date | Value |
---|---|
March 22, 2024 | 28.57% |
March 21, 2024 | 10.14% |
March 20, 2024 | 24.06% |
March 19, 2024 | 2.92% |
March 18, 2024 | 1.46% |
March 15, 2024 | 9.38% |
March 14, 2024 | 0.72% |
March 13, 2024 | 7.35% |
March 12, 2024 | 0.70% |
March 11, 2024 | 7.69% |
March 08, 2024 | -3.18% |
March 07, 2024 | -4.38% |
March 06, 2024 | -6.25% |
March 05, 2024 | -11.90% |
March 04, 2024 | -12.50% |
March 01, 2024 | -3.70% |
February 29, 2024 | -14.02% |
February 28, 2024 | -17.07% |
February 27, 2024 | -22.16% |
February 26, 2024 | -26.34% |
February 23, 2024 | -41.94% |
February 22, 2024 | -42.41% |
February 21, 2024 | -40.89% |
February 20, 2024 | -46.61% |
February 16, 2024 | -47.06% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.42%
Minimum
Jun 13 2022
378.0%
Maximum
Jul 10 2023
-30.43%
Average
-49.68%
Median
Apr 21 2020
1 Year Total Returns (Daily) Benchmarks
Cyclacel Pharmaceuticals Inc | -85.14% |
Oragenics Inc | -63.93% |
Alpine Immune Sciences Inc | 763.8% |
Corvus Pharmaceuticals Inc | 46.30% |
MAIA Biotechnology Inc | 30.49% |